{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+protocol&page=46", "query": { "intervention": "Standard protocol", "page": 46 }, "page_size": 10 }, "pagination": { "page": 46, "page_size": 10, "total_count": 1959, "total_pages": 196, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+protocol&page=47&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+protocol&page=45&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-28T23:39:05.077Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00977041", "title": "Neurofeedback Treatment of Pain in Persons With Spinal Cord Injury (SCI)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Spinal Cord Injuries", "Pain" ], "interventions": [ { "name": "Neurofeedback", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 13, "start_date": "2010-08", "completion_date": "2011-10", "has_results": false, "last_update_posted_date": "2013-06-06", "last_synced_at": "2026-10-28T23:39:05.077Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00977041" }, { "nct_id": "NCT07896070", "title": "Impact of Higher Zinc Supplementation on Neonatal Weight Velocity", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Extreme Prematurity,Extremely Low Birthweight", "BPD - Bronchopulmonary Dysplasia", "Growth" ], "interventions": [ { "name": "1 mg/day Zinc Supplementation", "type": "DRUG" }, { "name": "3 mg/day Zinc Supplementation", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Augusta University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Weeks", "maximum_age": "34 Weeks", "sex": "ALL", "summary": "25 Weeks to 34 Weeks" }, "enrollment_count": 30, "start_date": "2026-08-01", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-10-26", "last_synced_at": "2026-10-28T23:39:05.077Z", "location_count": 1, "location_summary": "Augusta, Georgia", "locations": [ { "city": "Augusta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07896070" }, { "nct_id": "NCT03496207", "title": "A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pulmonary Arterial Hypertension" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Sotatercept", "type": "DRUG" }, { "name": "SOC", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 106, "start_date": "2018-06-13", "completion_date": "2022-03-09", "has_results": true, "last_update_posted_date": "2023-04-19", "last_synced_at": "2026-10-28T23:39:05.077Z", "location_count": 12, "location_summary": "Phoenix, Arizona • Tucson, Arizona • San Francisco, California + 7 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03496207" }, { "nct_id": "NCT07413172", "title": "Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dry Eye", "Eye Diseases", "Eyes Dry Chronic" ], "interventions": [ { "name": "Autologous Serum Tears (50% Autologous Serum Tears + 0.2% Sodium Hyaluronate)", "type": "BIOLOGICAL" }, { "name": "Biological - Autologous Serum Tears (50% Autologous Serum Tears + Balanced Saline Solution (BSS)", "type": "BIOLOGICAL" }, { "name": "Standard of Care (SOC) Treatment", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2026-07-21", "completion_date": "2028-07", "has_results": false, "last_update_posted_date": "2026-07-24", "last_synced_at": "2026-10-28T23:39:05.077Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07413172" }, { "nct_id": "NCT01746511", "title": "Glycerin Suppositories to Reduce Jaundice in Premature Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Idiopathic Hyperbilirubinemia", "Neonatal Hyperbilirubinemia", "Prematurity" ], "interventions": [ { "name": "Phototherapy", "type": "PROCEDURE" }, { "name": "glycerin suppository", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "University of Rochester", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Weeks", "maximum_age": "35 Weeks", "sex": "ALL", "summary": "30 Weeks to 35 Weeks" }, "enrollment_count": 79, "start_date": "2012-07", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2015-12-09", "last_synced_at": "2026-10-28T23:39:05.077Z", "location_count": 1, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01746511" }, { "nct_id": "NCT02747875", "title": "Methadone vs. Fentanyl Administration on Postoperative Pain Control in Pediatric Patients Undergoing Cardiac Surgery", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Opioid Use, Unspecified" ], "interventions": [ { "name": "Methadone", "type": "DRUG" }, { "name": "Fentanyl", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Andrew Waberski", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": "7 Years", "sex": "ALL", "summary": "2 Years to 7 Years" }, "enrollment_count": 26, "start_date": "2016-09", "completion_date": "2019-02-07", "has_results": true, "last_update_posted_date": "2021-06-01", "last_synced_at": "2026-10-28T23:39:05.077Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02747875" }, { "nct_id": "NCT03682081", "title": "Interventions for Patients With Alzheimer's Disease and Dysphagia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dementia", "Dysphagia", "Alzheimer Disease" ], "interventions": [ { "name": "Isometric tongue strengthening facilitated by Iowa Oral Performance Instrument (IOPI)", "type": "DEVICE" }, { "name": "Biotene Oral Balance Gel", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "50 Years to 99 Years" }, "enrollment_count": 76, "start_date": "2020-09-25", "completion_date": "2025-11-30", "has_results": false, "last_update_posted_date": "2026-07-15", "last_synced_at": "2026-10-28T23:39:05.077Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT03682081" }, { "nct_id": "NCT03304587", "title": "Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer Survivors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Polysomnography (PSG)", "type": "DIAGNOSTIC_TEST" }, { "name": "Rectal thermistor 400 Series", "type": "DIAGNOSTIC_TEST" }, { "name": "Bright blue-green light", "type": "OTHER" }, { "name": "Dim red light", "type": "OTHER" }, { "name": "Digital foot candle datalogging light meter", "type": "DIAGNOSTIC_TEST" }, { "name": "Patient-Reported Outcomes Measurement Information System (PROMIS)-Cancer-Fatigue", "type": "OTHER" }, { "name": "Patient-Reported Outcomes Measurement Information System (PROMIS)-Sleep Disturbance", "type": "OTHER" }, { "name": "Patient-Reported Outcomes Measurement Information System (PROMIS)-Depression", "type": "OTHER" }, { "name": "Patient-Reported Outcomes Measurement Information System (PROMIS)-Physical Function", "type": "OTHER" }, { "name": "Pittsburgh Sleep Quality Index (PSQI)", "type": "OTHER" }, { "name": "Center for Epidemiological Studies - Depression", "type": "OTHER" }, { "name": "Montreal Cognitive Assessment (MoCA)", "type": "OTHER" }, { "name": "European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire (EORTC QLQ-C30)", "type": "OTHER" }, { "name": "Daily Log", "type": "OTHER" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "Michigan State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "FEMALE", "summary": "21 Years and older · Female only" }, "enrollment_count": 30, "start_date": "2017-11-06", "completion_date": "2022-08-31", "has_results": true, "last_update_posted_date": "2025-06-10", "last_synced_at": "2026-10-28T23:39:05.077Z", "location_count": 1, "location_summary": "East Lansing, Michigan", "locations": [ { "city": "East Lansing", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03304587" }, { "nct_id": "NCT05753449", "title": "Burst-Type Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Parkinson Disease", "Deep Brain Stimulation" ], "interventions": [ { "name": "Baseline (or standard of care) DBS programming", "type": "DEVICE" }, { "name": "Burst-type DBS electrical stimulation programming", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 2, "start_date": "2022-08-24", "completion_date": "2024-02-21", "has_results": true, "last_update_posted_date": "2025-05-28", "last_synced_at": "2026-10-28T23:39:05.077Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05753449" }, { "nct_id": "NCT03737643", "title": "Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Advanced Ovarian Cancer" ], "interventions": [ { "name": "Bevacizumab", "type": "DRUG" }, { "name": "Durvalumab", "type": "DRUG" }, { "name": "Olaparib", "type": "DRUG" }, { "name": "Placebo olaparib", "type": "DRUG" }, { "name": "Durvalumab placebo", "type": "DRUG" }, { "name": "Carboplatin+Paclitaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "FEMALE", "summary": "18 Years to 130 Years · Female only" }, "enrollment_count": 1407, "start_date": "2019-01-04", "completion_date": "2026-12-23", "has_results": true, "last_update_posted_date": "2026-07-07", "last_synced_at": "2026-10-28T23:39:05.077Z", "location_count": 26, "location_summary": "Foothill Ranch, California • Los Angeles, California • Orange, California + 22 more", "locations": [ { "city": "Foothill Ranch", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03737643" } ] }